AVEXIS

AveXis , doing business as Novartis Gene Therapies, Inc., is a biotechnology company that specializes in the development and commercialization of gene therapies for patients and families affected by rare and life-threatening neurological genetic diseases. AveXis was acquired by Novartis on May 14, 2018. In 2020, the company was renamed Novartis Gene Therapies.

#People #Financial #Website #More

AVEXIS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Genetics Health Care Medical

Founded:

2013-01-01

Address:

Dallas, Texas, United States

Country:

United States

Website Url:

http://www.avexis.com

Total Employee:

11+

Status:

Closed

Contact:

847.572.8280

Email Addresses:

[email protected]

Total Funding:

75.1 M USD

Technology used in webpage:

SPF Domain Not Resolving IPv6 Microsoft Azure DNS Mobile Optimized ASP.NET MVC Comcast Proofpoint DocuSign Incapsula

Current Employees Featured

lucie-bruijn_image

Lucie Bruijn
Lucie Bruijn Senior Director, Translational Medicine, EMEA @ AveXis
Senior Director, Translational Medicine, EMEA
2020-01-01

sean-p-nolan_image

Sean P. Nolan
Sean P. Nolan President & Chief Executive Officer @ AveXis
President & Chief Executive Officer
2015-06-01

phillip-donenberg_image

Phillip Donenberg
Phillip Donenberg Senior Vice President, Chief Financial Officer @ AveXis
Senior Vice President, Chief Financial Officer
2017-10-01

michael-b-johannesen_image

Michael B. Johannesen
Michael B. Johannesen Senior Vice President, General Counsel, and Chief Compliance Officer @ AveXis
Senior Vice President, General Counsel, and Chief Compliance Officer